Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00055042
Status:
COMPLETED
Last Update Posted:
2008-03-04
First Post:
2003-02-15
Brief Title:
Laser and Antioxidant Treatment of Diabetic Macular Edema
Sponsor:
National Eye Institute NEI
Organization:
National Institutes of Health Clinical Center CC
Study Overview
Official Title:
Laser and Antioxidant Treatment of Diabetic Macular Edema
Status:
COMPLETED
Status Verified Date:
2004-01
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study will compare the side effects of two laser treatments for diabetic macular edema a common condition in patients with diabetes In macular edema blood vessels in the retina-a thin layer of tissue that lines the back of the eye-become leaky and the retina swells The macula-the center part of the retina that is responsible for fine vision-may also swell and cause vision loss Traditional laser treatment argon blue or green or yellow for macular swelling or edema causes scarring that can expand and possibly lead to more loss of vision A different type of laser diode may have less damaging effects to the eye and fewer long-term adverse effects but this is not known The results of this study on side effects of the treatments will be used to design a larger study of effectiveness The study will also examine whether vitamin E can reduce the damage caused by laser treatment Patients with elevated cholesterol levels will be invited to participate in a cholesterol reduction part of the study to compare normal-pace cholesterol reduction with accelerated reduction
Patients 18 years of age and older with type 1 or type 2 diabetes and macular edema may be eligible for this study Candidates will be screened with the following tests and procedures
Medical history and physical examination
Eye examination to assess visual acuity eye chart test and eye pressure and to examine pupils lens retina and eye movements The pupils will be dilated with drops for this examination
Blood tests to measure cholesterol and vitamin E blood levels blood clotting time hemoglobin A1C a measure of diabetes control and to evaluate liver and kidney function
Eye photography to help evaluate the status of the retina and changes that may occur in the future Special photographs of the inside of the eye are taken using a camera that flashes a bright light into the eye
Fluorescein angiography to evaluate the eyes blood vessels A yellow dye is injected into an arm vein and travels to the blood vessels in the eyes Pictures of the retina are taken using a camera that flashes a blue light into the eye The pictures show if any dye has leaked from the vessels into the retina indicating possible blood vessel abnormality
Multifocal electroretinogram to measure electrical responses generated within the retina The test which takes about 1-12 hours is painless
Participants will be randomly assigned to take 1600 IU of vitamin E or placebo an inactive look-alike pill daily After taking the pills for 3 months or more patients who require laser treatment will be randomly assigned to one of the two laser therapies Patients with macular edema in both eyes will receive both treatments one in each eye For these procedures eye drops are put in the eye to numb the surface and a contact lens is placed on the eye during the laser beam application Several visits may be required for additional laser treatments The maximum number of treatments depends on how well they are working Patients will return for follow-up visits 1 3 and 6 months after the first treatment and then every 6 months until either the patient returns for a 3-year visit the last enrolled patient returns for the 1-year visit or the patient requests to leave the study During the follow-up visits patients response to treatment will be evaluated with repeat tests of several of the screening exams
Patients 18 years of age and older with type 1 or type 2 diabetes and macular edema may be eligible for this study Candidates will be screened with the following tests and procedures
Medical history and physical examination
Eye examination to assess visual acuity eye chart test and eye pressure and to examine pupils lens retina and eye movements The pupils will be dilated with drops for this examination
Blood tests to measure cholesterol and vitamin E blood levels blood clotting time hemoglobin A1C a measure of diabetes control and to evaluate liver and kidney function
Eye photography to help evaluate the status of the retina and changes that may occur in the future Special photographs of the inside of the eye are taken using a camera that flashes a bright light into the eye
Fluorescein angiography to evaluate the eyes blood vessels A yellow dye is injected into an arm vein and travels to the blood vessels in the eyes Pictures of the retina are taken using a camera that flashes a blue light into the eye The pictures show if any dye has leaked from the vessels into the retina indicating possible blood vessel abnormality
Multifocal electroretinogram to measure electrical responses generated within the retina The test which takes about 1-12 hours is painless
Participants will be randomly assigned to take 1600 IU of vitamin E or placebo an inactive look-alike pill daily After taking the pills for 3 months or more patients who require laser treatment will be randomly assigned to one of the two laser therapies Patients with macular edema in both eyes will receive both treatments one in each eye For these procedures eye drops are put in the eye to numb the surface and a contact lens is placed on the eye during the laser beam application Several visits may be required for additional laser treatments The maximum number of treatments depends on how well they are working Patients will return for follow-up visits 1 3 and 6 months after the first treatment and then every 6 months until either the patient returns for a 3-year visit the last enrolled patient returns for the 1-year visit or the patient requests to leave the study During the follow-up visits patients response to treatment will be evaluated with repeat tests of several of the screening exams
Detailed Description:
This randomized pilot study is an important first step in planning a large multi-center clinical trial to evaluate medical and laser approaches that could improve the visual outcome for patients with diabetic retinopathy This study will provide preliminary safety and efficacy data on these therapies as well as allow for assessment of the performance of ocular outcomes and study design for use in subsequent trials If there are no safety concerns the results of this pilot will be helpful in the design of a large multicenter clinical trial by providing data on estimates of expected treatment effects
Using a factorial design this study will compare 1 photocoagulation using a diode micropulse laser to mild Early Treatment Diabetic Retinopathy Studt ETDRS style continuous wave laser using green or yellow wavelength focal photocoagulation and 2 the effect of treating with antioxidants high dose Vitamin E to placebo prior to and following laser photocoagulation The primary outcome is a visual acuity drop or increase of 15 letters or more from baseline three year after enrollment The secondary outcomes will be a 50 reduction in retinal thickening as measured by Optical Cohenrence Tomography OT a two-step reduction in macular thickness when compared to standard stereoscopic fundus photographs and a 50 reduction in the area of leakage as measured by fluorescein angiography at 1 year amd 3 years after the initial laser compared to baseline Additional outcomes will include the time from baseline of the first laser treatment and the number of retreatments required during the course of the study These outcomes will be assessed for potential use in future trials We are concerned with the following specific questions regarding safety and efficacy
Safety
Is the risk of visual loss in patients with clinically significant diabetic macular edema potentially different across treatment groups
Efficacy
Is there any evidence that any treatment combinations could be effective in reducing retinal thickening
Is there any evidence that Vitamin E may affect the ability of either photocoagulation method to reduce retinal thickening or vice versa
What are the estimated treatment effects on vision
Is the number of laser treatments required to achieve a reduction in retinal thickening similar across treatment groups
A tertiary objective of this study will be to examine the effects of dramatically reducing low-density lipoproteins cholesterol in patients with diabetic macular edema and elevated serum lipids Change in vision and change in retinal thickness will be compared across three groups 1 patients who do not have elevated serum lipids at baseline 2 patients who have elevated lipids at baseline and receive standard of care treatment and 3 patients who have elevated lipids at baseline and are aggressively treated pharmacologically This tertiary objective will be assessed for the feasibility of this randomization
Using a factorial design this study will compare 1 photocoagulation using a diode micropulse laser to mild Early Treatment Diabetic Retinopathy Studt ETDRS style continuous wave laser using green or yellow wavelength focal photocoagulation and 2 the effect of treating with antioxidants high dose Vitamin E to placebo prior to and following laser photocoagulation The primary outcome is a visual acuity drop or increase of 15 letters or more from baseline three year after enrollment The secondary outcomes will be a 50 reduction in retinal thickening as measured by Optical Cohenrence Tomography OT a two-step reduction in macular thickness when compared to standard stereoscopic fundus photographs and a 50 reduction in the area of leakage as measured by fluorescein angiography at 1 year amd 3 years after the initial laser compared to baseline Additional outcomes will include the time from baseline of the first laser treatment and the number of retreatments required during the course of the study These outcomes will be assessed for potential use in future trials We are concerned with the following specific questions regarding safety and efficacy
Safety
Is the risk of visual loss in patients with clinically significant diabetic macular edema potentially different across treatment groups
Efficacy
Is there any evidence that any treatment combinations could be effective in reducing retinal thickening
Is there any evidence that Vitamin E may affect the ability of either photocoagulation method to reduce retinal thickening or vice versa
What are the estimated treatment effects on vision
Is the number of laser treatments required to achieve a reduction in retinal thickening similar across treatment groups
A tertiary objective of this study will be to examine the effects of dramatically reducing low-density lipoproteins cholesterol in patients with diabetic macular edema and elevated serum lipids Change in vision and change in retinal thickness will be compared across three groups 1 patients who do not have elevated serum lipids at baseline 2 patients who have elevated lipids at baseline and receive standard of care treatment and 3 patients who have elevated lipids at baseline and are aggressively treated pharmacologically This tertiary objective will be assessed for the feasibility of this randomization
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 03-EI-0064 | None | None | None |